K. Elmasry

发表

Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer.

J. Crow, C. Perrett, A. Maclean, 2010, European journal of gynaecological oncology.

Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer

A. Maclean, G. Boxer, R. Begent, 2011, Angiogenesis.

Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study

D. Evans, A. Davies, K. Reynolds, 2009, Familial Cancer.

Ovarian cancer aetiology: facts and fiction

S. Gayther, K. Elmasry, 2006, Journal of Family Planning and Reproductive Health Care.

Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.

I. Jacobs, C. Rodeck, I. Jacobs, 2007, Human reproduction.

Predicting Clinical Outcome in Patients Diagnosed with Synchronous Ovarian and Endometrial Cancer

A. Gammerman, Zhiyuan Luo, J. Whittaker, 2008, Clinical Cancer Research.

Cancer Diagnosis, Risk Assessment and Prediction of Therapeutic Response by Means of DNA Methylation Markers

H. Fiegl, K. Elmasry, 2007, Disease markers.

Genetic mutations in gynaecological cancers

S. Gayther, K. Elmasry, 2006 .

Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).

K. Elmasry, Marwa Fakhreldin, 2016, Vaccine.

Screening for ovarian cancer: progress and challenges

K. Elmasry, 2006, Journal of Family Planning and Reproductive Health Care.